Immune barriers to successful gene therapy

Trends in Molecular Medicine

Volumn 15, Issue 1, 2009, Pages 32-39

  Wu, Te Lang ^a   Ertl, Hildegund C J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; LENTIVIRUS VECTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR; RAPAMYCIN;

ADAPTIVE IMMUNITY; ADENOVIRUS; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; GENE THERAPY; GENE TRANSFER; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; TRANSGENE;

CD8-POSITIVE T-LYMPHOCYTES; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNITY, INNATE; T-LYMPHOCYTES, REGULATORY; VIRUSES;

EID: 58149481281     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2008.11.005     Document Type: Review

References (84)

1. Manno C.S., et al. Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat. Med. 12 (2006) 342-347
2. Maguire A.M., et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358 (2008) 2240-2248
3. Bainbridge J.W., et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 358 (2008) 2231-2239
4. Cideciyan A.V., et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 15112-15117
5. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 286 (1999) 2244-2245
6. Bangari D.S., and Mittal S.K. Current strategies and future directions for eluding adenoviral vector immunity. Curr. Gene Ther. 6 (2006) 215-226
7. Epstein A.L., et al. HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy. Curr. Gene Ther. 5 (2005) 445-458
8. Muruve D.A., et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452 (2008) 103-107
9. Vandenberghe L.H., et al. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat. Med. 12 (2006) 967-971
10. Prasad S.A., et al. Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells. J. Immunol. 166 (2001) 4809-4812
11. Wang S., and Chen L. Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses. Microbes Infect. 6 (2004) 759-766
12. + effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J. Exp. Med. 197 (2003) 181-193
13. Dong H., et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5 (1999) 1365-1369
14. Latchman Y., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2 (2001) 261-268
15. Watanabe N., et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4 (2003) 670-679
16. Sedy J.R., et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6 (2005) 90-98
17. Suh W.K., et al. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat. Immunol. 4 (2003) 899-906
18. Sica G.L., et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18 (2003) 849-861
19. Zhu J., et al. A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo. Mol. Ther. 16 (2008) 1300-1307
20. McCaffrey A.P., et al. The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver. Mol. Ther. 16 (2008) 931-941
21. Brown B.D., et al. In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109 (2007) 2797-2805
22. Okunishi K., et al. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J. Immunol. 175 (2005) 4745-4753
23. low/neg accessory cells with dendritic-cell features. Blood 108 (2006) 218-227
24. Munn D.H., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297 (2002) 1867-1870
25. Munn D.H., and Mellor A.L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J. Clin. Invest. 117 (2007) 1147-1154
26. Della Chiesa M., et al. The tryptophan catabolite l-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood 108 (2006) 4118-4125
27. López-Larrea C., et al. The NKG2D receptor: sensing stressed cells. Trends Mol. Med. 14 (2008) 179-189
28. + T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors. J. Immunol. 175 (2005) 6032-6041
29. Reske A., et al. Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells. J. Immunol. 180 (2008) 7525-7536
30. Mauri D.N., et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 8 (1998) 21-30
31. Campadelli-Fiume G., et al. The multipartite system that mediates entry of herpes simplex virus into the cell. Rev. Med. Virol. 17 (2007) 313-326
32. de Jong M.A., et al. Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J. Gen. Virol. 89 (2008) 2398-2409
33. Gringhuis S.I., et al. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26 (2007) 605-616
34. Breckpot K., et al. Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors. Hum. Gene Ther. 18 (2007) 536-546
35. Georgel P., et al. Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362 (2007) 304-313
36. Zhang Y., et al. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells. J. Virol. 74 (2000) 8003-8010
37. Chiriva-Internati M., et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells. Eur. J. Immunol. 32 (2002) 30-38
38. Jooss K., and Chirmule N. Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther. 10 (2003) 955-963
39. Zaiss A.K., and Muruve D.A. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Gene Ther. 15 (2008) 808-816
40. Follenzi A., et al. Immune responses to lentiviral vectors. Curr. Gene Ther. 7 (2007) 306-315
41. + T cell cross-priming via transfer of proteasome substrates. Science 304 (2004) 1318-1321
42. Yang Y., et al. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3 (1996) 137-144
43. Follenzi A., et al. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103 (2004) 3700-3709
44. + T cells in mice. J. Clin. Invest. 117 (2007) 3958-3970
45. + T-cell responses to adeno-associated virus capsid in humans. Nat. Med. 13 (2007) 419-422
46. Sojka D.K., et al. Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology 124 (2008) 13-22
47. + regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9 (2008) 239-244
48. + regulatory T cells. J. Leukoc. Biol. 81 (2007) 144-153
49. + T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Blood 110 (2007) 1132-1140
50. Niederkorn J.Y. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7 (2006) 354-359
51. Galea I., et al. What is immune privilege (not)?. Trends Immunol. 28 (2007) 12-18
52. Hori J., et al. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 177 (2006) 5928-5935
53. Niederkorn J.Y., and Wang S. Immune privilege of the eye and fetus: parallel universes?. Transplantation 80 (2005) 1139-1144
54. Usui Y., et al. Functional expression of B7H1 on retinal pigment epithelial cells. Exp. Eye Res. 86 (2008) 52-59
55. Beutelspacher S.C., et al. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur. J. Immunol. 36 (2006) 690-700
56. Stein-Streilein J., and Taylor A.W. An eye's view of T regulatory cells. J. Leukoc. Biol. 81 (2007) 593-598
57. Nasr I.W., et al. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. J. Immunol. 174 (2005) 6161-6168
58. Worgall S., et al. Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA. Hum. Gene Ther. 19 (2008) 463-474
59. Byrnes A.P., et al. Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 3 (1996) 644-651
60. Xiong W., et al. Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses. J. Virol. 80 (2006) 27-37
61. Suzuki M., et al. Stable transgene expression from HSV amplicon vectors in the brain: potential involvement of immunoregulatory signals. Mol. Ther. 16 (2008) 1727-1736
62. Bennett J. Immune response following intraocular delivery of recombinant viral vectors. Gene Ther. 10 (2003) 977-982
63. Hoffman L.M., et al. Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest. Ophthalmol. Vis. Sci. 38 (1997) 2224-2233
64. Mingozzi F., et al. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J. Clin. Invest. 111 (2003) 1347-1356
65. Sumpter T.L., et al. Dendritic cells, the liver, and transplantation. Hepatology 46 (2007) 2021-2031
66. Freedman J., and Garvey M.B. Immunoadsorption of factor VIII inhibitors. Curr. Opin. Hematol. 11 (2004) 327-333
67. Tydén G., et al. Present techniques for antibody removal. Transplantation 84 (2007) S27-S29
68. Le H.T., et al. Utility of PEGylated recombinant adeno-associated viruses for gene transfer. J. Control. Release 108 (2005) 161-177
69. Wang C., and Pham P.T. Polymers for viral gene delivery. Expert Opin. Drug Deliv. 5 (2008) 385-401
70. Gao G., et al. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6081-6086
71. Shen X., et al. Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency. Mol. Ther. 15 (2007) 1955-1962
72. Litjens N.H., et al. Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur. J. Immunol. 34 (2004) 565-575
73. Mingozzi F., et al. Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver. Blood 110 (2007) 2334-2341
74. Jiang Z., et al. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle. Gene Ther. 11 (2004) 1453-1461
75. Jiang Z.L., et al. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle. Mol. Ther. 3 (2001) 892-900
76. Jiang Z., et al. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade. Mol. Ther. 10 (2004) 688-696
77. Haegel-Kronenberger H., et al. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys. Gene Ther. 11 (2004) 241-252
78. Ndejembi M.P., et al. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. J. Immunol. 177 (2006) 7698-7706
79. Mirenda V., et al. Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood 109 (2007) 2968-2977
80. Mahajan S., et al. The role of ICOS in the development of CD4 T cell help and the reactivation of memory T cells. Eur. J. Immunol. 37 (2007) 1796-1808
81. Vu M.D., et al. Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J. Immunol. 176 (2006) 1394-1401
82. +T cells in mice. Transpl. Immunol. 17 (2007) 153-161
83. + regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177 (2006) 8338-8347
84. Brown B.D., et al. A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 110 (2007) 4144-4152